TickerStat.comwe like data

Protalix BioTherapeutics, Inc. (PLX)

Price—Loading quote
PLXNYSE
Loading local price history

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

17 annual periodsNewest to oldest
20252024202320222021202020192018201720162015201420132012201120102009
Revenue$52.7M$53.4M$65.5M$47.6M$38.4M$62.9M$54.7M$34.2M$21.1M$9.2M$4.4M$3.5M$10.5M$34.9M$8.4M$6.6M$388,000
Gross profit$25.8M$29.1M$42.5M$28.0M$22.0M$52.0M$43.8M$24.9M$4.0M$801,000$3.6M$2.9M$6.1M$26.3M$1.4M$6.9M−$3.2M
Gross margin48.82%54.46%64.91%58.87%57.37%82.71%80.08%72.83%19.03%8.71%83.27%82.12%58.07%75.37%17.21%103.30%−821.39%
Research & development$19.6M$13.0M$17.1M$29.3M$29.7M$38.2M$44.6M$33.3M$32.2M$30.4M$24.9M$27.4M$29.2M$36.7M$37.8M$37.7M$27.4M
Operating expenses$31.3M$25.2M$32.1M$41.1M$42.5M$49.3M$54.5M$44.2M$38.5M$34.0M$27.3M$31.5M$40.1M$38.5M$38.0M$36.8M$28.8M
Operating income−$5.5M$3.9M$10.5M−$13.0M−$20.5M$2.7M−$10.7M−$19.3M−$34.5M−$33.2M−$23.7M−$28.6M−$34.1M−$12.2M−$36.5M−$30.0M−$32.0M
Operating margin−10.43%7.34%15.97%−27.32%−53.36%4.31%−19.59%−56.39%−163.76%−360.51%−542.39%−810.64%−325.06%−34.91%−435.62%−451.16%−8,239.43%
EBITDA−$4.0M$5.2M$11.7M−$11.9M−$19.3M$4.0M−$9.1M−$17.6M−$32.6M−$31.2M−$21.3M−$25.4M−$30.5M−$8.5M———
EBITDA margin−7.65%9.78%17.79%−25.04%−50.44%6.38%−16.64%−51.51%−154.65%−338.95%−488.08%−721.52%−291.29%−24.32%———
Net income−$6.6M$2.9M$8.3M−$14.9M−$27.6M−$6.5M−$18.3M−$26.5M−$83.4M−$29.4M$58.0M−$29.9M−$27.8M−$11.6M−$36.5M−$29.0M−$31.4M
Net profit margin−12.52%5.49%12.69%−31.33%−71.92%−10.37%−33.42%−77.27%−395.86%−319.22%1,329.90%−849.93%−265.20%−33.32%−435.60%−436.59%−8,103.09%
Basic EPSper basic share-$0.08$0.04$0.12-$0.31-$0.62-$0.22-$1.23-$1.80-$6.37-$2.90$6.10-$3.20-$3.00-$1.30-$4.30-$3.60$4.10
Diluted EPSper diluted share-$0.08$0.04$0.09-$0.31-$0.62-$0.22-$1.23-$1.80-$6.37-$2.90$6.10-$3.20-$3.00-$1.30-$4.30-$3.60$4.10
Review official source filings ↗

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 20 reported holders of PLX
HolderShares held
BlackRock, Inc.
4.05M
Bashan Dror
2.53M
RENAISSANCE TECHNOLOGIES LLC
1.1M
STATE STREET CORP
983.58K
GEODE CAPITAL MANAGEMENT, LLC
980K
NORTHERN TRUST CORP
922.34K
Rubin Eyal
660.91K
VANGUARD PORTFOLIO MANAGEMENT LLC
510.64K
Stratos Wealth Partners, LTD.
500K
DIMENSIONAL FUND ADVISORS LP
493.42K
GOLDMAN SACHS GROUP INC
475.92K
MARSHALL WACE, LLP
452.76K
CITADEL ADVISORS LLC
334.23K
Schwartz Aharon
310.5K
STRS OHIO
296.1K
Bank of New York Mellon Corp
232.99K
Naos Yaron
232.93K
Main Street Financial Solutions, LLC
214.1K
BRIDGEWAY CAPITAL MANAGEMENT, LLC
189.1K
Hillsdale Investment Management Inc.
185.71K

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys2$307.8K disclosed value
Sells (SEC code S)1$314.16 disclosed value
3 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Dec 19, 2025Form 4Bashan DrorPRESIDENT AND CEOBuyCommon Stock56.0K$1.81$101.4K188.5K
Nov 18, 2025Form 4Bar-Shalev AmosDirectorSellCommon Stock168$1.87$314.160
Jun 10, 2025Form 4Schwartz AharonDirectorBuyCommon Stock129.0K$1.60$206.4K303.0K
Review ownership filings at SEC.gov ↗

Community posts

View community

It’s quiet here.

No posts about PLX yet. Start the conversation.

Write the first post